- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04025333
Helping Ethnic Minority in Hong Kong to Quit Smoking by Understanding Their Knowledge, Attitude and Behavior Related to Smoking
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Cigarette smoking is the most significant preventable cause of death and disease, causing 6 million deaths annually worldwide. Despite the fact that tobacco use in Hong Kong has been decreased from 23.3% in 1982 to 10.1% in 2017, the remaining 620 600 daily smokers[3] cannot be overlooked or undervalued.
Hong Kong is a predominantly Chinese society, but it has a sizeable South Asian ethnic minority (EM). According to the Census & Statistics Department, the number of ethnic minorities in Hong Kong increased significantly by 70.8% over the past 10 years. Nevertheless, few smoking and health promotion activities and smoking cessation services have been tailor-made for ethnic minorities in Hong Kong. The barrier of supplying smoking cessation service to the ethnic minority group is that their smoking motivation, willingness to quit, obstacles of quit smoking, attitude towards Hong Kong tobacco law and smoking cessation services are not sure. This will be the first research exploring their knowledge, attitude and experience of cigarette smoking.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Hong Kong, Hong Kong
- The University of Hong Kong
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Only smokers with South Asian(Pakistani, Indian, or Nepalese)backgrounds
- Willing to participate
- aged 18 years or above
- able to speak English
- smoke at least one cigarette per day for the past 3 months
Exclusion Criteria:
- Domestic workers, asylum seekers, refugees, or illegal immigrants, individuals with other ethnic backgrounds, i.e., Africans
- Cannot speak English
- poor cognitive state or active psychotic symptoms, i.e. hallucination, illusion and delusion, noted in the medical records.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The smoking behaviour among ethnic minorities in Hong Kong.
Tidsramme: at the baseline
|
Participants were asked about:
|
at the baseline
|
|
The knowledge of the risk of smoking in ethnic minorities in Hong Kong.
Tidsramme: at the baseline
|
Participants were asked about their knowledge of the risk of smoking.
|
at the baseline
|
|
Attitudes towards smoking, tobacco control and smoking cessation in ethnic minorities in Hong Kong.
Tidsramme: at the baseline
|
Participants were asked about
|
at the baseline
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- UW 18-514
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .